PET (positron emission tomography) and LINACs (linear accelerators) called for in NHS Scotland funding
This article was originally published in Clinica
Executive Summary
The National Health Service in Scotland is to get £27m ($43m) over the next three years to acquire linear accelerators and positron emission tomography (PET) units, after being awarded budget increases of up to 20% per year to improve equipment and services over this period. The capital investment programme announced on March 18 2003 will see the current £275m budget rise to £420m in 2005-06.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.